spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Abbott 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 10 Jul 2024
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 24 Apr 2024
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 25 Mar 2024
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
Devices Oncology Personnel
 HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2024
PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
Diagnostics Oncology Personnel
 HSMN NewsFeed - 13 Dec 2023
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2023
Abbott Completes Acquisition of Bigfoot Biomedical
Devices Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 5 Jul 2023
Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
Devices Cardiology FDA
 HSMN NewsFeed - 29 Jun 2023
Shane Brown Promoted to President of GT Medical Technologies, Inc.
Devices Oncology Personnel
 HSMN NewsFeed - 19 May 2023
Abbott Receives FDA Approval for TactiFlex(TM) Ablation Catheter for Treatment of Abnormal Heart Rhythm
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 12 May 2023
NeuroBo Pharmaceuticals, Inc. Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Devices Neurology FDA
 HSMN NewsFeed - 19 Dec 2022
Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
Devices FDA Product Launch
 HSMN NewsFeed - 13 Dec 2022
Neurolief Appoints Neuromodulation Industry Leader Scott Drees as CEO
Devices Neurology Personnel
 HSMN NewsFeed - 21 Nov 2022
Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure(R) Predict Prognostic Test for Alzheimer's Disease
Diagnostics Neurology Personnel
 HSMN NewsFeed - 9 Sep 2022
Nouscom Strengthens Leadership Team with the Appointments of Sven Gogov, MD, as Chief Medical Officer and Maria Arce-Tomas, PhD, as VP, Head of Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Aug 2022
ImmPACT Bio Names Vikram Lamba as Chief Financial Officer and Head of Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jun 2022
MicroTransponder Raises $53M, Appoints New CEO
Devices Neurology Personnel Venture Capital
 HSMN NewsFeed - 14 Jun 2022
Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2022
Abbott's FreeStyle Libre(R) 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 19 May 2022
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 May 2022
Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 May 2022
Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
Diagnostics FDA
 HSMN NewsFeed - 28 Apr 2022
Abbott Strengthens Left Atrial Appendage Closure Leadership With U.S. Availability of Amplatzer(TM) Steerable Delivery Sheath for the Company's Amulet(TM) Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 7 Apr 2022
Sherlock Biosciences Appoints Karen Davies as Chief Development Officer
Diagnostics Personnel
 HSMN NewsFeed - 30 Mar 2022
Pathalys Pharma Announces Executive Team Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2022
Abbott's FreeStyle(R) Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin
Devices Monitoring Reimbursement
 HSMN NewsFeed - 21 Feb 2022
Abbott's CardioMEMS(TM) HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 17 Jan 2022
CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jan 2022
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 11 Jan 2022
ACELYRIN Appoints Melanie Gloria as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2022
Abbott's Proclaim(TM) XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.
Devices Neurology Radiology FDA
 HSMN NewsFeed - 3 Jan 2022
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2021
Chemomab Therapeutics Names Donald R. Marvin Chief Financial Officer, Executive Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2021
Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2021
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2021
Baylis Medical Announces First Clinical Case Using the VersaCross(R) Large Access Solution in Canada
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Aug 2021
Abbott's Amplatzer(TM) Amulet(TM) Device Approved by FDA to Treat People With Atrial Fibrillation at Risk of Stroke
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 2 Aug 2021
Abbott's FreeStyle(R) Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 2 Aug 2021
ElectroPhysiology Frontiers announces appointment of Avi Fischer, M.D. as CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 30 Jun 2021
Abbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Jun 2021
Artio Medical Hires Key Sales and Marketing Leaders to Prepare for Commercial Launch of First Product in U.S.
Devices Interventional Personnel
 HSMN NewsFeed - 3 Jun 2021
Abbott Confirms Capacity to Support Expanded Use of HeartMate 3(TM) Heart Pump
Devices Cardiology
 HSMN NewsFeed - 3 Jun 2021
Medtronic to Stop Distribution and Sale of HVAD(TM) System
Devices Cardiology Distribution
 HSMN NewsFeed - 17 May 2021
Abbott Receives CE Mark for Navitor(TM), the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System to Treat Aortic Stenosis
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Apr 2021
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2021
Abbott Receives CE Mark Approval for Next-Generation TriClip(TM) Device, Offering New Innovations for Tricuspid Heart Valve Repair
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 8 Mar 2021
Abbott Introduces NeuroSphere(TM) Virtual Clinic, First-of-its-Kind Remote Neuromodulation Patient-Care Technology in the U.S.
Devices Neurology Product Launch
 HSMN NewsFeed - 24 Feb 2021
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 23 Feb 2021
Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2021
Actimed Therapeutics Appoints Frank Misselwitz MD, PhD as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2021
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Devices Neurology FDA
 HSMN NewsFeed - 20 Jan 2021
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 14 Jan 2021
Abbott to Launch the NeuroSphere(TM) myPath(TM) Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
Devices Neurology Monitoring Product Launch
 HSMN NewsFeed - 14 Dec 2020
Abbott Develops New Pedialyte(R) Hydration Solution to Help Support Immune Health
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 2 Dec 2020
Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Devices Monitoring Endocrinology Regulatory
 HSMN NewsFeed - 6 Nov 2020
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 5 Nov 2020
LifeScan Names Lisa Rose Chief Marketing Officer
Devices Monitoring Personnel
 HSMN NewsFeed - 3 Nov 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
Devices Oncology Personnel
 HSMN NewsFeed - 30 Oct 2020
Senior Leadership Appointments at TrackX Technology, Inc. : Ray Oktavec & Chris Helps
Devices Personnel
 HSMN NewsFeed - 11 Sep 2020
Targazyme Appoints Jim Caggiano as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2020
Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
Devices Monitoring Endocrinology Reimbursement
 HSMN NewsFeed - 10 Aug 2020
Werewolf Therapeutics Appoints Business Leader, Ellen Lubman, as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2020
Sight Sciences Announces First Patients Enrolled in ORION: A Prospective, Multicenter Clinical Trial of the OMNI Surgical System in Pseudophakic, Mild-to-Moderate Glaucoma Patients
Devices Ophthalmology
 HSMN NewsFeed - 4 Aug 2020
Abbott Announces Start of Study to Evaluate New Device to Treat Recurrent Atrial Fibrillation
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jul 2020
Jay Pharma to File IND Applications to FDA for a clinical study of proprietary formulations in Radiodermatitis and a combination Therapy in Glioblastoma
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jul 2020
Abbott Receives FDA Approval for iOS-Compatible App Allowing People Living With Chronic Pain and Movement Disorders to Personalize Therapy Via Their Mobile Device
Devices Neurology FDA
 HSMN NewsFeed - 6 Jul 2020
Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring
Devices Cardiology FDA
 HSMN NewsFeed - 2 Jul 2020
inHEART Raises $4.2 Million to Improve Treatments for Cardiac Arrhythmias With Medical Imaging, Artificial Intelligence and Numerical Simulations
Devices Cardiology Venture Capital
 HSMN NewsFeed - 15 Jun 2020
Abbott's FreeStyle(R) Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 11 May 2020
Abbott Receives FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity(TM) i System
Diagnostics FDA Product Launch
 HSMN NewsFeed - 7 May 2020
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 5 May 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams' Role Expanded To Chairman And CEO
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2020
Abbott's TriClip(TM) Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Mar 2020
EchoNous, Inc. Announces FDA Approval for Its New KOSMOS Platform
Devices FDA
 HSMN NewsFeed - 5 Mar 2020
Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav(TM) Delivery System for the Company's Portico(TM) Valve
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Feb 2020
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Devices Monitoring Drug Delivery Endocrinology
 HSMN NewsFeed - 18 Feb 2020
Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
Devices Cardiology Regulatory Product Launch
 HSMN NewsFeed - 4 Feb 2020
Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
Devices Cardiology FDA
 HSMN NewsFeed - 30 Jan 2020
Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Jan 2020
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Devices Neurology FDA
 HSMN NewsFeed - 24 Jan 2020
Anat Hakim to join Lilly as General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jan 2020
Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality
Devices Neurology Personnel
 HSMN NewsFeed - 10 Jan 2020
Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 9 Dec 2019
Sight Sciences Appoints Erica Rogers to its Board of Directors
Devices Ophthalmology Personnel
 HSMN NewsFeed - 13 Nov 2019
Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2019
Zyla Life Sciences Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2019
International MIGS Study Confirms Long-Term Safety and Efficacy of the OMNI(R) Surgical System Predicate Device (VISCO360(R))
Devices Ophthalmology
 HSMN NewsFeed - 26 Sep 2019
FDA Approves Abbott's "Low Dose," Recharge-Free Spinal Cord Stimulation System with up to Ten Year Battery Life* for People Living with Chronic Pain
Devices Neurology FDA
 HSMN NewsFeed - 17 Sep 2019
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Sep 2019
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
Devices Monitoring Endocrinology Reimbursement
 HSMN NewsFeed - 26 Aug 2019
Confirm BioSciences Announces Appointments of Albert Berger as New Chief Executive Officer and Nikhil Nayak as Chief Operating Officer
Diagnostics Personnel
 HSMN NewsFeed - 22 Aug 2019
Biofourmis Names Two Pharmaceutical Veterans to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2019
CeloNova Announces Appointment of New President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 6 Aug 2019
BioVentrix Announces Key Additions to Leadership Team
Devices Cardiology Personnel
 HSMN NewsFeed - 11 Jul 2019
Abbott Announces FDA Approval of the Alinity(TM) s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply
Diagnostics FDA
 HSMN NewsFeed - 2 Jul 2019
InMed Pharmaceuticals Appoints Catherine Sazdanoff to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jun 2019
Nevro Announces Executive Appointments
Devices Personnel
 HSMN NewsFeed - 7 Jun 2019
Vyaire Medical Announces Two New Leaders Reinforcing Company's Customer-First Growth Strategy
Devices Personnel
 HSMN NewsFeed - 27 May 2019
CathVision Expand Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 22 May 2019
Edwards Announces Milestones For Transcatheter Mitral Program
Devices Cardiology Interventional
 HSMN NewsFeed - 6 May 2019
Abbott Launches Next-generation Detection Technology in the U.S. and Europe, Offering a Smarter Approach to 24/7 Heart Monitoring for People with Irregular Heartbeats
Devices Monitoring Cardiology Product Launch
 HSMN NewsFeed - 2 May 2019
Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
Diagnostics HIV/AIDS Regulatory
 HSMN NewsFeed - 29 Apr 2019
New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events in Adults with No Known Heart Disease
Diagnostics Cardiology
 HSMN NewsFeed - 10 Apr 2019
BIOTRONIK Launches PK Papyrus Covered Coronary Stent in the USA
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 9 Apr 2019
Orgentec Diagnostika Appoints Global Healthcare Leader Gary Winer As President And CEO
Diagnostics Personnel
 HSMN NewsFeed - 19 Mar 2019
Abbott Announces CE Mark for Alinity(TM) m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients
Diagnostics Regulatory
 HSMN NewsFeed - 14 Mar 2019
FDA Approves New Indication for Valve Repair Device to Treat Certain Heart Failure Patients with Mitral Regurgitation
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 14 Mar 2019
Clinical Study Demonstrates Long Term IOP Reduction with the OMNI(R) Surgical System Predicate Device (TRAB(R)360) in Micro-Invasive Glaucoma Surgery
Devices Ophthalmology
 HSMN NewsFeed - 6 Feb 2019
Proteostasis Therapeutics Appoints Emmanuel Dulac and Kim Drapkin to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2019
Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 16 Jan 2019
Abbott To Acquire Cephea Valve Technologies, Inc.
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2018
New Approvals Allow Chronic Pain Sufferers to Try Abbott's Non-Opioid Pain Therapy Before Getting Device Implant
Devices Neurology FDA Regulatory Product Launch
 HSMN NewsFeed - 25 Oct 2018
Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
Diagnostics FDA Product Launch
 HSMN NewsFeed - 22 Oct 2018
EpiVax Oncology Appoints Dominique Bridon as Chief Technology Officer and Dan Adams to the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Oct 2018
Abbott's HeartMate 3 Heart Pump Now FDA Approved for Advanced Heart Failure Patients Not Eligible for a Heart Transplant
Devices Cardiology FDA
 HSMN NewsFeed - 15 Oct 2018
Abbott Names Robert B. Ford President, Chief Operating Officer
Diagnostics Devices Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2018
IFM Therapeutics, LLC Appoints John Leonard, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 10 Sep 2018
Medivir Appoints Dr. Linda Basse as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Aug 2018
Rockwell Medical Appoints New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2018
Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
Devices Neurology FDA
 HSMN NewsFeed - 26 Jul 2018
Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jul 2018
FDA Grants Approval of TIBSOVO(R), the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Jul 2018
Spruce Biosciences Appoints David Moriarty, Ph.D., as Vice President of Development Operations
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 26 Jun 2018
Caris Life Sciences Expands Management Team
Diagnostics Personnel
 HSMN NewsFeed - 21 Jun 2018
Alimera Sciences Appoints Mary T. Szela to its Board of Directors
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 14 Jun 2018
Allergan Continues Active Board Refreshment Process
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2018
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
Diagnostics Endocrinology Product Launch
 HSMN NewsFeed - 23 May 2018
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 23 May 2018
Abbott's Investigational Tendyne(TM) Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2018
Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions
Devices Interventional Cardiology
 HSMN NewsFeed - 3 May 2018
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
Devices Cardiology FDA
 HSMN NewsFeed - 2 Apr 2018
INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2018
Abbott Initiates Trial to Evaluate Improved Survival And Outcomes with the CardioMEMS Monitor
Devices Monitoring Cardiology
 HSMN NewsFeed - 20 Mar 2018
Mark Stenhouse to join Exact Sciences as President, Cologuard
Diagnostics Oncology Personnel
 HSMN NewsFeed - 19 Mar 2018
Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation
Devices Cardiology Reimbursement
 HSMN NewsFeed - 13 Mar 2018
Astellas Announces Key Leadership Changes in Legal, Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2018
Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon
Devices Interventional Licensing
 HSMN NewsFeed - 7 Feb 2018
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
Devices Monitoring Endocrinology Product Launch
 HSMN NewsFeed - 22 Jan 2018
Johnson & Johnson Vision Expands Parameter Offering for 1-DAY ACUVUE(R) MOIST Brand Contact Lenses for ASTIGMATISM
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 15 Jan 2018
Nitto Avecia Pharma Services Appoints Raymond Kaczmarek as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2018
New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices
Devices Cardiology Radiology FDA
 HSMN NewsFeed - 2 Jan 2018
Abbott Launches Alinity(TM) h-series Integrated Hematology System, Combining Speed, Accuracy and Seamless Integration
Devices Diagnostics Product Launch
 HSMN NewsFeed - 19 Dec 2017
Disarm Therapeutics Appoints Peter Keller Chief Business Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 18 Dec 2017
Robert Stewart to Join Amneal Pharmaceuticals as President
Biopharmaceuticals Personnel Mergers & Acquisitions
 HSMN NewsFeed - 29 Nov 2017
Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
Devices Personnel
 HSMN NewsFeed - 13 Nov 2017
Spruce Biosciences Appoints Camilla V. Simpson to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces TearScience LipiScan(R) and LipiFlow(R) Now Available in More Than 800 Eye Care Practices to Image Meibomian Glands and Treat Meibomian Gland Dysfunction
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces Series of Product Milestones and Launches Across Portfolio at American Academy of Ophthalmology 2017 Meeting
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 6 Nov 2017
Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 31 Oct 2017
Abbott Announces FDA Clearance for its Alinity(TM) ci-series Next-generation Diagnostic Systems
Diagnostics FDA
 HSMN NewsFeed - 30 Oct 2017
Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1]
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 23 Oct 2017
Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.
Devices Monitoring Cardiology FDA Product Launch
 HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2017
EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 22 Sep 2017
Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse(TM) ICD
Devices Cardiology FDA
 HSMN NewsFeed - 18 Sep 2017
Urovant Sciences Appoints Keith A. Katkin as Chief Executive Officer
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 31 Aug 2017
Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabalin in Diabetic Peripheral Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 28 Aug 2017
ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2017
Abbott Introduces HeartMate 3 Left Ventricular Assist System - the Latest Milestone In Therapy For Advanced Heart Failure Patients
Devices Cardiology FDA Product Launch
 HSMN NewsFeed - 14 Aug 2017
MaxCyte Appoints Executive Vice President of Global Marketing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Aug 2017
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 25 Jul 2017
Roxwood Medical Announces Agreement with Abbott for Distribution of Products in U.S.
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 5 Jul 2017
Matthew Gantz Appointed CEO of OxThera
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2017
Pharmavite Appoints Matthew Roberts to New Role of Executive Vice President, Chief Technical and Quality Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2017
Merit Medical Announces Appointment of New Director
Devices Interventional Cardiology Radiology Personnel
 HSMN NewsFeed - 8 May 2017
Abbott Announces National Reimbursement for FreeStyle(R) Libre in France, Providing Access to Revolutionary Technology for People with Diabetes
Diagnostics Endocrinology Reimbursement
 HSMN NewsFeed - 21 Apr 2017
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR(12) Rates in Challenging to Treat Genotype 3 Chronic Hepatitis C
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2017
Abbott and Alere Amend Terms of Merger Agreement
Biopharmaceuticals Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 12 Apr 2017
Cellectar Biosciences Strengthens Management Team with Appointment of John Friend, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Apr 2017
Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs
Regenerative Medicine Personnel
 HSMN NewsFeed - 30 Mar 2017
U.S. FDA Approves Addition of Moderate to Severe Fingernail Psoriasis Data to AbbVie's HUMIRA(R) (adalimumab) Prescribing Information
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Mar 2017
Forty Seven Inc. Announces Mark McCamish, M.D., Ph.D., to Join as CEO on May 1st
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Mar 2017
ALK Announces FDA Approval for its House Dust Mite Sublingual Allergy Immunotherapy Tablet (ACARIZAX(R) in Europe)
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Feb 2017
Glaukos Corporation Promotes Chris M. Calcaterra to Chief Operating Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 19 Jan 2017
U.S. FDA Approves IMBRUVICA(R) (ibrutinib) as First Treatment Specifically Indicated for Relapsed/Refractory Marginal Zone Lymphoma (MZL) - a Rare Type of Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Jan 2017
Abbott Announces U.S. Launch and First Commercial Use of the New EnSite(TM) Precision Cardiac Mapping System
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 5 Jan 2017
Abbott Completes the Acquisition of St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 19 Dec 2016
AbbVie Submits New Drug Application to U.S. FDA for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of All Major Genotypes of Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Dec 2016
Biogen and AbbVie Receive Health Canada Approval of Once-Monthly ZINBRYTA(TM) (Daclizumab Beta) for Multiple Sclerosis
Biopharmaceuticals Nerurology Regulatory
 HSMN NewsFeed - 28 Nov 2016
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Nov 2016
AbbVie's HUMIRA(R) (Adalimumab) Receives CHMP Positive Opinion to Treat Adolescents with Hidradenitis Suppurativa, a Chronic Inflammatory Skin Disease
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 14 Nov 2016
Technopath Clinical Diagnostics Launches its First Diagnostic Reagent Product, the i-plaq(TM) Test for Lp-PLA2
Diagnostics Cardiology Product Launch
 HSMN NewsFeed - 7 Nov 2016
Abbott's Absorb(TM) Bioresorbable Stent Approved as the First Fully Dissolving Heart Stent in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 25 Oct 2016
Miracor Receives Additional Funding in Series-C Closing to Expand Clinical and Commercial Activities with the PiCSO(R) Impulse System
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 21 Oct 2016
Alere Shareholders Approve Merger with Abbott
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 20 Oct 2016
Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 18 Oct 2016
St. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation
Devices Interventional Acquisitions
 HSMN NewsFeed - 6 Oct 2016
Novaliq Strengthens Executive Management Team by Appointing Christian Roesky, PhD, as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 28 Sep 2016
Abbott Receives FDA Approval for the FreeStyle Libre Pro(TM) System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 26 Sep 2016
AbbVie Announces Submission of a Supplemental New Drug Application for Ibrutinib (IMBRUVICA(R)) for Treatment of Marginal Zone Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Sep 2016
AbbVie Presents Data on Eight-Week Treatment of VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C
Biopharmaceuticals
 HSMN NewsFeed - 26 Aug 2016
Alere Issues Statement
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 27 Jul 2016
Carl Zeiss Meditec Recruits James V. Mazzo to Lead its Newly Consolidated Ophthalmology Organization
Devices Ophthalmology Personnel
 HSMN NewsFeed - 29 Jun 2016
AbbVie Announces Fourth Breakthrough Therapy Designation Granted by the U.S. Food and Drug Administration (FDA) for Ibrutinib (IMBRUVICA(R)) for Chronic Graft-Versus-Host-Disease (cGVHD), a Rare Condition with Limited Treatment Options
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2016
Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 27 May 2016
AbbVie's HUMIRA(R) (adalimumab) Receives CHMP Positive Opinion to Treat Certain Forms of Non-Infectious Uveitis, a Disease that Can Severely Impact Vision
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 9 May 2016
U.S. FDA Expands IMBRUVICA(R) (ibrutinib) Label to Include Overall Survival Data in Previously Untreated Chronic Lymphocytic Leukemia (CLL) and New Indication for Small Lymphocytic Lymphoma (SLL) Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Apr 2016
Abbott to Acquire St. Jude Medical
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 21 Apr 2016
Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity
Diagnostics Product Launch
 HSMN NewsFeed - 19 Apr 2016
Rodney D. Altman, MD Joins Valeritas Board of Directors
Devices Drug Delivery Endocrinology Personnel
 HSMN NewsFeed - 15 Apr 2016
AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2016
AbbVie Announces Real-World Data with VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) and EXVIERA(R) (dasabuvir tablets) from Large German Hepatitis C-Registry
Biopharmaceuticals
 HSMN NewsFeed - 4 Apr 2016
AbbVie Receives CHMP Positive Opinion for HUMIRA(R) (adalimumab) for the Treatment of Pediatric Patients, from Six Years of Age, with Moderately to Severely Active Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 16 Mar 2016
Abbott's Absorb(TM), the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Mar 2016
Heart Metabolics Announces Multiple Senior Appointments To Management Team
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 4 Mar 2016
Astellas Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2016
AbbVie Receives EMA Orphan Drug Designation for Investigational Compound Venetoclax for the Treatment of Acute Myeloid Leukemia (AML)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Feb 2016
Abbott Receives Approval in Australia for FreeStyle(R) Libre--the Revolutionary Glucose Monitoring System for People with Diabetes
Devices Endocrinology Monitoring Regulatory
 HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 10 Feb 2016
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 4 Feb 2016
GTCR Announces Third Partnership with Ed Fiorentino to Form TerSera(TM) Therapeutics
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 4 Feb 2016
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Feb 2016
Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence
Devices Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 28 Jan 2016
Venetoclax Receives 3rd Breakthrough Therapy Designation from the FDA for the Combination Treatment of Patients with Untreated Acute Myeloid Leukemia not Eligible for Standard Induction Chemotherapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jan 2016
AbbVie's Venetoclax Receives Breakthrough Therapy Designation from FDA in Combination with Rituximab for the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jan 2016
Oncimmune Appoints Greg Stanley as President of Commercial Operations
Diagnostics Oncology Personnel
 HSMN NewsFeed - 8 Jan 2016
MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline
Diagnostics Oncology Personnel
 HSMN NewsFeed - 6 Jan 2016
AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only Health Canada Approval for Moderate to Severe Hidradenitis Suppurativa
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2015
AbbVie Submits IMBRUVICA(R) (ibrutinib) Phase III Combination Data to U.S. FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Nov 2015
Insys Therapeutics Announces Senior Management Changes and Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2015
Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylan's Over-the-Counter Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2015
Timothy P. Walbert Joins Sucampo's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2015
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Sep 2015
AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) Receives Approval in Japan for the Treatment of Genotype 1 Chronic Hepatitis C
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Sep 2015
Marathon Pharmaceuticals Names Dr. Jordan Dubow Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2015
Mylan Commences Offer to Acquire Perrigo
Biopharmaceuticals Generic Mergers & Acquisitions
 HSMN NewsFeed - 11 Sep 2015
AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 10 Sep 2015
Protagonist Therapeutics Names Richard S. Shames, M.D. as Chief Medical Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 8 Sep 2015
Selecta Biosciences Appoints Earl E. Sands, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2015
Summit Therapeutics Appoints Ralf Rosskamp, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2015
CeQur Announces $100 Million Series C Financing
Devices Drug Delivery Endocrinology Venture Capital
 HSMN NewsFeed - 28 Aug 2015
Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2015
Cantex Pharmaceuticals Enhances Executive Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Jul 2015
Abbott to Broaden Foundation in Structural Heart Therapies with Two Mitral Valve Transactions
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 27 Jul 2015
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization Application for Empliciti (elotuzumab) For the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 7 Jul 2015
Diadexus, Inc. Names William Hammond as Vice President of Sales
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 6 Jul 2015
Darin Leigh Joins Metabolon as Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 6 Jul 2015
OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2015
Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 30 Apr 2015
ConvaTec Appoints Paul Moraviec CEO Effective April 30, 2015
Devices Personnel
 HSMN NewsFeed - 27 Apr 2015
Akorn Announces Recent Executive Appointments
Biopharmaceuticals Generic Personnel
 HSMN NewsFeed - 30 Mar 2015
Novan Secures $50 Million Private Financing
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 10 Mar 2015
Presbia Announces the Promotion of Dumitra Nela Gonzales to Vice President of Regulatory Affairs and Quality Assurance
Devices Ophthalmology Personnel
 HSMN NewsFeed - 11 Feb 2015
Xagenic Hires Vice President of Product Development to Expand Molecular Diagnostic Offerings and Speed Pipeline-to-Market
Diagnostics Personnel
 HSMN NewsFeed - 16 Jan 2015
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA(R) (dasabuvir tablets) for the Treatment of Chronic Hepatitis C
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Dec 2014
Apricus Biosciences Appoints Barbara Troupin, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Nov 2014
Intellia Therapeutics Announces $15 Million in Funding to Develop Therapeutic Products Utilizing CRISPR-Cas9 Gene Editing Technology
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Oct 2014
Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 3 Oct 2014
Ophthotech Corporation Names Todd N. Smith as Chief Commercial Officer
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 26 Aug 2014
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2014
Rosetta Genomics Expands Management Team With Appointment of Douglas Sites as Executive Vice President of Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 7 Aug 2014
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
Devices Personnel
 HSMN NewsFeed - 4 Aug 2014
RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2014
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 14 Jul 2014
Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 20 Jun 2014
ERBA Diagnostics, Inc. Appoints William Creech as Vice President Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 9 Jun 2014
Giovanni Caforio, M.D., Appointed Chief Operating Officer and Elected to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2014
Immune Appoints Gad Berdugo to Board of Directors and Karin Hehenberger, M.D., Ph.D to Senior Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2014
Senseonics Raises $20 Million
Devices Monitoring Endocrinology Personnel
 HSMN NewsFeed - 19 May 2014
Ventrus Biosciences to Merge With Assembly Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 May 2014
Avedro Welcomes Robert J. Palmisano to its Board of Directors
Devices Ophthalmology Personnel
 HSMN NewsFeed - 1 May 2014
EndoGastric Solutions Names Industry Veteran Skip Baldino CEO
Devices Personnel
 HSMN NewsFeed - 30 Apr 2014
Abbott's First-of-Its-Kind MitraClip(R) Device Now Approved in Canada
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 28 Apr 2014
Sanovas Expands Management Team
Devices Personnel
 HSMN NewsFeed - 22 Apr 2014
Cellnovo Strengthens Senior Management Team with Three Key Hires
Devices Endocrinology Personnel
 HSMN NewsFeed - 14 Apr 2014
Abbott Announces FDA Clearance for a New Test to Help Physicians Quickly and Accurately Diagnose Diabetes
Diagnostics Endocrinology FDA
 HSMN NewsFeed - 4 Mar 2014
SharedClarity Awards First Contracts
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 13 Feb 2014
Regulus Appoints Head of Regulus microMarkers(TM) R&D Division
Biopharmaceuticlas Personnel
 HSMN NewsFeed - 5 Feb 2014
Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Feb 2014
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2014
AbbVie Announces Initiation of Pivotal Phase 3 Study of Veliparib (ABT-888) for Patients with Early-Stage Triple-Negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Jan 2014
Covidien, Lightstone Ventures, New Enterprise Associates Announce Series A Investment in FIRE1
Devices Venture Capital Personnel
 HSMN NewsFeed - 7 Jan 2014
Lipocine Announces New Appointments to Its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Jan 2014
Guided Therapeutics Names Gene Cartwright as Chief Executive Officer
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Diagnostics Oncology Personnel
 HSMN NewsFeed - 11 Dec 2013
Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2013
Novelos Therapeutics Announces a Restructuring of Its Board of Directors and Additional Changes to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Nov 2013
Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and Certain African Countries
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 25 Oct 2013
Abbott's First-In-Class MitraClip(R) Device Now Available for U.S. Patients
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 24 Oct 2013
Mallinckrodt Pharmaceuticals Announces Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2013
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
Devices Diagnostics Monitoring Regulatory
 HSMN NewsFeed - 5 Sep 2013
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Hematology Analyzers, Automation, Reagents, Consumables and Service
Diagnostics Group Purchasing
 HSMN NewsFeed - 4 Sep 2013
New Data Suggests Abbott's High Sensitive Troponin Test May Help Doctors More Accurately Diagnose Heart Attacks in Women
Diagnostics Cardiology
 HSMN NewsFeed - 27 Aug 2013
Sunshine Heart Welcomes Dr. Patrick Verta as Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 23 Aug 2013
Bosch Healthcare Reacquires the Rights to Its Patents in the Diabetes Field from Abbott
Devices Endocrinology Monitoring Licensing
 HSMN NewsFeed - 21 Aug 2013
Abbott Completes Acquisition of IDEV Technologies
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2013
Enteris BioPharma Appoints Timothy J. Saxon, Vice President of Business Development, to Expand "Peptelligence(TM) Partnering" Program
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 19 Aug 2013
Abbott Completes Acquisition of OptiMedica
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 16 Aug 2013
Emergent BioSolutions Appoints Barry Labinger as Executive Vice President of the Company and President of Its Biosciences Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2013
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Drug/Non-Drug Eluting Coronary Stents, Diagnostic and Interventional Cardiology Products
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 6 Aug 2013
James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
Biopharmaceuticals Drug Delivery Ophthalmology Personnel
 HSMN NewsFeed - 25 Jul 2013
Abbott Receives FDA Clearance for FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System(TM)
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 19 Jul 2013
Royalty Pharma Announces Marshall Urist, MD, PhD, Joins Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2013
Abbott to Enter Laser Cataract Surgery Market through Acquisition of OptiMedica
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 15 Jul 2013
Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 10 Jul 2013
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 Jul 2013
Accelerate Diagnostics Appoints Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 26 Jun 2013
GlySure Appoints William Moffitt as Executive Chairman
Devices Monitoring Personnel
 HSMN NewsFeed - 25 Jun 2013
Multiplicom Appoints Dr. Ian Gilham as Chairman of the Board
Diagnostics Personnel
 HSMN NewsFeed - 10 Jun 2013
Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 30 May 2013
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2013
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 May 2013
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Diagnostics Endocrinology Regulatory
 HSMN NewsFeed - 18 Apr 2013
Abbott Announces FDA Approval and U.S. Launch of the TECNIS(R) Toric Intraocular Lens for Cataract Patients
Devices Ophthalmology FDA Product Launch
 HSMN NewsFeed - 16 Apr 2013
Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand
Diagnostics Product Launch
 HSMN NewsFeed - 15 Apr 2013
Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2013
David A. Dodd Appointed President & Chief Executive Officer of Aeterna Zentaris Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2013
Royalty Pharma Announces Firm Offer to Acquire Elan
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Apr 2013
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx(R) Blood Glucose Meters in the United States
Devices Monitoring Endocrinology Product Recall
 HSMN NewsFeed - 5 Mar 2013
Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2013
Hansen Medical Appoints Will Sutton as Chief Operating Officer Responsible for Engineering and Manufacturing
Devices Personnel
 HSMN NewsFeed - 28 Jan 2013
Endologix Announces Presentation of Data From PEVAR Randomized Trial
Devices Interventional
 HSMN NewsFeed - 15 Jan 2013
Galectin Therapeutics Appoints Industry Veteran Rex Horton as Executive Director of Regulatory Affairs and Quality Assurance
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Jan 2013
Pathway Genomics Names Todd G. Johnson as Vice President of Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 8 Jan 2013
Abbott Initiates Clinical Trial of Absorb(TM) in the United States
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2013
Predictive Biosciences Appoints Diagnostics Industry Veteran Pierre Cassigneul as Chief Executive Officer
Diagnostics Oncology Urology Personnel
 HSMN NewsFeed - 2 Jan 2013
Abbott Completes Separation of Research-Based Pharmaceuticals Business
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2012
Sequenom Announces Leadership Appointments
Diagnostics Personnel
 HSMN NewsFeed - 10 Dec 2012
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2012
Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Nov 2012
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Nov 2012
Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Nov 2012
Abbott Announces First Long-term Patient-reported Health Outcomes Data for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2012
Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 31 Oct 2012
Abaxis Announces Exclusive Distribution Agreement with Abbott
Diagnostics Distribution
 HSMN NewsFeed - 24 Oct 2012
Abbott's ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 22 Oct 2012
STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing(R) Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Oct 2012
Abbott Announces Three-Year Long-Term Data Evaluating Efficacy with HUMIRA(R) (Adalimumab) For Patients with Moderately to Severely Active Ulcerative Colitis
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Sep 2012
Apricus Biosciences' Wholly-Owned Subsidiary NexMed (U.S.A.) and Takeda Pharmaceuticals International GmbH Sign Exclusive License Agreement to Market Vitaros(R) in the United Kingdom
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Sep 2012
Integra LifeSciences Announces Two Key Executive Appointments
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 4 Sep 2012
STAAR Surgical Builds Leadership Team to Drive Growth Opportunities
Devices Ophthalmology Personnel
 HSMN NewsFeed - 24 Aug 2012
ZELTIQ(R) Aesthetics Appoints Mark J. Foley as President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 20 Aug 2012
Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Aug 2012
Abbott's Omnilink Elite(R) Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 1 Aug 2012
Lpath Appoints Daniel L. Kisner, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2012
Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
Diagnostics Personalized Medicine Gastroenterology
 HSMN NewsFeed - 26 Jul 2012
Durata Therapeutics Adds Independent Director Lisa M. Giles to the Company’s Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jul 2012
Insulet Appoints W. Mark Lortz to Board of Directors
Devices Endocrinology Personnel
 HSMN NewsFeed - 10 Jul 2012
Abbott Announces New Test for the Management of Patients with Diabetes
Diagnostics Endocrinology Regulatory
 HSMN NewsFeed - 21 Jun 2012
Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jun 2012
Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Peripheral Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2012
Abbott Announces 10-Year Data Evaluating HUMIRA(R) (Adalimumab) for Patients with Long-Standing Moderate-to-Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2012
Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA(R) (Adalimumab) in Patients with Active Non-radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2012
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 30 May 2012
Kona Medical Secures $30M in Financing to Pursue Novel Hypertension Therapy
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 21 May 2012
GenVec Appoints Cynthia Collins as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2012
PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
Piramal Healthcare Limited to Acquire Decision Resources Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 May 2012
Abbott's XIENCE PRIME(TM) and XIENCE V(R) Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 May 2012
Piramal Healthcare Presents Positive Results of Pivotal Phase III Clinical Trial for BST-CarGel(R) at the World Congress of the International Cartilage Repair Society (ICRS)
Devices Orthopaedic
 HSMN NewsFeed - 8 May 2012
SpineGuard Expands U.S. Sales Organization and Creates Four “Areas” to Support Growing Number of Independent Distributors Marketing Its PediGuard(R) Product Family
Devices Orthopaedic Neurosurgery Personnel Distribution
 HSMN NewsFeed - 7 May 2012
Advanced Cardiac Therapeutics Announces Several Key Appointments
Devices Cardiology Personnel
 HSMN NewsFeed - 3 May 2012
Creabilis Appoints Dr Simon Russell as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2012
Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2012
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2012
Abbott Receives U.S. FDA Clearance to Use iFS Advanced Femtosecond Laser Technology for Arcuate Incisions in Cataract Surgery
Devices Ophthalmology FDA
 HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Diagnostics Personalized Medicine Oncology Licensing
 HSMN NewsFeed - 16 Apr 2012
QLT Announces the Appointment of Christopher Muller as Chief Commercial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Apr 2012
Abbott Receives Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Apr 2012
InspireMD Appoints Robert Ratini as Vice President of Sales and Marketing
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 5 Apr 2012
Syndax Pharmaceuticals Appoints Arthur M. Pappas to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Mar 2012
Seattle Genetics Appoints Dr. Nancy Simonian to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Mar 2012
Abbott's Absolute Pro(R) Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 6 Mar 2012
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 29 Feb 2012
Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2012
Vein Illumination Leader AccuVein Inc. Announces Daniel Delaney as Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 6 Feb 2012
Auxilium Announces Appointments to Enhance Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2012
Ronnie Andrews Joins Life Technologies as President, Medical Sciences
Diagnostics Personnel
 HSMN NewsFeed - 10 Jan 2012
Interwest Partners Expands Medical Devices Team
Devices Venture Capital Personnel
 HSMN NewsFeed - 22 Dec 2011
Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 8 Dec 2011
Abbott Initiates Clinical Trial to Evaluate the Absorb(TM) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Dec 2011
Auxilium Pharmaceuticals, Inc. Appoints Adrian Adams Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Nov 2011
Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels
Diagnostics FDA
 HSMN NewsFeed - 30 Nov 2011
Boston Scientific Introduces Industry-Leading ICD and CRT-D Device Warranties
Devices Cardiology
 HSMN NewsFeed - 16 Nov 2011
Alphatec Spine Appoints New Senior Vice President, Global Marketing and Asia Pacific
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 14 Nov 2011
Catalyst Pharmaceutical Partners Appoints Richard P. Rieger as Vice President, Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Nov 2011
Systagenix Adds Two Members to Board of Directors
Devices Wound Care Personnel
 HSMN NewsFeed - 8 Nov 2011
Abbott Reports Five-Year Data for HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2011
Abbott Presents HUMIRA(R) (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis
Biopharmaceuticals
 HSMN NewsFeed - 4 Nov 2011
Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Nov 2011
Abbott to Present Broad Spectrum of Compelling Data for HUMIRA(R) (Adalimumab) at American College of Rheumatology Annual Scientific Meeting
Biopharmaceuticals
 HSMN NewsFeed - 1 Nov 2011
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 Oct 2011
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
Diagnostics FDA
 HSMN NewsFeed - 19 Oct 2011
Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals
Biopharmaceuticals Devices Diagnostics
 HSMN NewsFeed - 18 Oct 2011
EBR Systems, Inc. Appoints Allan Will President and Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 14 Oct 2011
Health Discovery Corporation Agrees with the U.S. Preventive Services Task Force’s Position Against PSA-Based Screening for Prostate Cancer and Believes Its Four-Gene Assay for Prostate Cancer is the Best Alternative to PSA
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Oct 2011
Echo Therapeutics Hires Product Development Management Executive
Devices Monitoring Personnel
 HSMN NewsFeed - 4 Oct 2011
Creabilis Raises 15M ($20M) in Series B Fundraising Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Sep 2011
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2011
NPS Pharmaceuticals Appoints Eric Pauwels as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2011
Neurologix Appoints Adrian Adams as Company Chairman and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Sep 2011
Elan Announces Board of Director Changes
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Sep 2011
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia
Devices
 HSMN NewsFeed - 27 Aug 2011
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Diagnostics Personalized Medicine Oncology FDA
 HSMN NewsFeed - 27 Aug 2011
U.S. Food And Drug Administration Approves Pfizer’s XALKORI(R) (crizotinib) As First And Only Therapy Specifically For Patients With Locally Advanced Or Metastatic ALK-Positive Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Aug 2011
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 22 Aug 2011
FDA Clears Abbott's Genetic FISH Panel for Leukemia Patient Prognosis
Diagnostics Oncology FDA
 HSMN NewsFeed - 2 Aug 2011
Echo Therapeutics Hires Seasoned Diabetes Management Executive
Devices Monitoring Endocrinology Personnel
 HSMN NewsFeed - 28 Jul 2011
Genzyme and Isis Announce Submission of European Marketing Authorization Application for Mipomersen (Kynamro(R))
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jul 2011
BioSante Pharmaceuticals Announces Management Team Additions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2011
Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Biopharmaceuticals
 HSMN NewsFeed - 6 Jul 2011
Celldex Expands Senior Management Team with Appointment of Dr. Ronald A. Pepin, Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2011
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot(R) (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 17 Jun 2011
Seattle Genetics Announces Promotion of Eric Dobmeier to Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2011
Animas(R) Vibe, the First Integrated Offering from Animas Corporation and Dexcom, Inc., Receives European CE Mark Approval
Devices Monitoring Drug Delivery Regulatory
 HSMN NewsFeed - 25 May 2011
Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS(R) 2.25 mm Everolimus-Eluting Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2011
Abbott Receives FDA Approval for Molecular Test for Hepatitis C
Diagnostics FDA
 HSMN NewsFeed - 17 May 2011
Former Pharma Executive, Dr. Dominique Bridon, Joins Optivia Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2011
Abbott's HUMIRA(R) (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 6 May 2011
Cytori Announces Clyde W. Shores as Executive Vice President of Marketing & Sales
Regenerative Medicine Personnel
 HSMN NewsFeed - 29 Apr 2011
NeurogesX CEO Anthony DiTonno to Retire by Year End
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2011
Alphatec Holdings Announces Appointment of Patrick Ryan as Chief Operating Officer
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2011
PLUS Diagnostics Names David Pauluzzi Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 4 Apr 2011
Data From Landmark Clinical Trial of Abbott's MitraClip(R) System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
Devices Cardiology
 HSMN NewsFeed - 29 Mar 2011
PhaseRx Appoints Richard P. Rieger Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2011
FDA Clears Abbott's i-STAT(R) 1 Wireless Point of Care Testing System
Devices Diagnostics FDA
 HSMN NewsFeed - 28 Mar 2011
Abbott Introduces Micro-Implantation Cataract Suite
Devices Ophthalmology
 HSMN NewsFeed - 28 Mar 2011
Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Mar 2011
Access Pharmaceuticals Appoints Industry Executive Anthony Mottola as Vice President of Managed Care and Market Access
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 18 Mar 2011
Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development
Diagnostics Personalized Medicine Mergers & Acquisitions
 HSMN NewsFeed - 10 Mar 2011
Agendia Hires David Macdonald as Chief Operating Officer, Mark Willig as Executive VP of North American Sales, and Doug Bradley as Vice President of Global Marketing
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 8 Mar 2011
Ortho Kinematics Appoints New VP of Sales and Director of Clinical Operations
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 25 Feb 2011
REVA Expands Management Team With Key Executive Hire
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 25 Feb 2011
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Peripheral and Biliary Stents
Devices Interventional Group Purchasing
 HSMN NewsFeed - 23 Feb 2011
Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
Biopharmaceuticals Litigation
 HSMN NewsFeed - 31 Jan 2011
Abbott's TREK(R) Coronary Balloon System Now Available in the United States and Japan
Devices Interventional Cardiology Regulatory FDA
 HSMN NewsFeed - 12 Jan 2011
Genelux Corporation Appoints Jodi Devlin as President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2011
Insulet Appoints Charles Liamos as Chief Operating Officer
Devices Endocrinology Personnel
 HSMN NewsFeed - 10 Jan 2011
Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 29 Dec 2010
Radient Pharmaceuticals Signs Distribution Agreement With Hong Kong Based Bio-Asia Diagnostics Co. Ltd.
Diagnostics Distribution
 HSMN NewsFeed - 22 Dec 2010
Abbott and AstraZeneca End License Agreement for the Development of CERTRIAD
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Dec 2010
Ramius and Royalty Pharma Extend Tender Offer Until January 5, 2011 Pursuant to Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Dec 2010
Gilead Sciences to Acquire Arresto Biosciences for $225 Million
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Dec 2010
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2010
Watson and Richter Announce Exclusive License Agreement for Esmya
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Dec 2010
AVI BioPharma Names Chris Garabedian Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2010
Study Shows Novartis Drug Afinitor(R) Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2010
CombiMatrix Receives Acceptance Notice for Listing on the Nasdaq Capital Market; Hires New Director of Sales
Diagnostics Personnel
 HSMN NewsFeed - 2 Dec 2010
Faheem Hasnain Named President and Chief Executive Officer of Receptos
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2010
BG Medicine Announces FDA 510(k) Clearance of its Galectin-3 Test for Use in Patients with Chronic Heart Failure
Diagnostics Cardiology FDA
 HSMN NewsFeed - 16 Nov 2010
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Diagnostic and Interventional Cardiology Products
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 8 Nov 2010
Ambit Biosciences Strengthens Board of Directors and Executive Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Nov 2010
New Anti-TNF Study Shows Patients With Rheumatoid Arthritis Receiving REMICADE(R) After Inadequate Response to Enbrel(R) or Humira(R) Demonstrate Marked Clinical Improvement
Biopharmaceuticals
 HSMN NewsFeed - 5 Nov 2010
Metamark Genetics, Inc. Announces New Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 27 Oct 2010
Laurence J. Downey, MD Joins Arbor Pharmaceuticals as Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2010
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Drug and Non-Drug Eluting Coronary Stents
Devices Interventional Cardiology Group Purchasing
 HSMN NewsFeed - 26 Oct 2010
Myriad and Abbott Enter Into Cooperative Agreement
Diagnostics Oncology
 HSMN NewsFeed - 19 Oct 2010
Pearl Therapeutics Raises $69 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Sep 2010
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Outstanding Two-Year Clinical Results Versus TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2010
Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2010
Susan Hertzberg Named CEO of Boston Heart Lab; Company Closes $10 Million in Series C Financing with Bain Capital Ventures as Lead Investor
Diagnostics Personnel Venture Capital
 HSMN NewsFeed - 20 Sep 2010
Celera Signs Agreement with Abbott for Distribution of CE-marked KIF6 Test to Identify Patients at Risk of Coronary Heart Disease
Diagnostics Cardiology Distribution
 HSMN NewsFeed - 13 Sep 2010
Aegerion Pharmaceuticals Appoints Marc Beer as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2010
STAAR Surgical Launches New Visian ICL Product Line Extensions at ESCRS
Devices Ophthalmology
 HSMN NewsFeed - 8 Sep 2010
Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Aug 2010
Hospira Announces CEO Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2010
SonoSite Announces Non-Executive Chairman Kirby Cramer's Retirement; Dr. Robert Hauser Appointed as New Chairman
Devices Personnel
 HSMN NewsFeed - 30 Jul 2010
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2010
Actient Pharmaceuticals, LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Jul 2010
Abbott's SIMCOR(R) (niacin extended-release / simvastatin) Receives FDA Approval for New Dosage Strengths
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 22 Jul 2010
HYCOR Biomedical Announces Senior Executive Appointments
Diagnostics Personnel
 HSMN NewsFeed - 20 Jul 2010
AcuFocus Names Ophthalmic Sales Veteran Mike Judy as Chief Commercialization Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 20 Jul 2010
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jul 2010
Abbott's PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 2 Jul 2010
Olivier Bohuon Joins Pierre Fabre
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2010
Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
Diagnostics FDA
 HSMN NewsFeed - 21 Jun 2010
FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 16 Jun 2010
Eurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals Business
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2010
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 3 Jun 2010
Abbott Receives FDA Clearance for New Ovarian Cancer Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 1 Jun 2010
CoaguSense Receives FDA Clearance for the CoaguSense Blood Coagulation Testing System for Patient Home Use
Devices Diagnostics Monitoring FDA
 HSMN NewsFeed - 26 May 2010
The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery
Devices Interventional
 HSMN NewsFeed - 26 May 2010
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 May 2010
Abbott Announces European Launch of TREK(TM) Catheter System, Representing an Advancement in Balloon Technology
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 May 2010
Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Abbott's Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
Devices Cardiology
 HSMN NewsFeed - 21 May 2010
Abbott to Become No. 1 Pharmaceutical Company in India with Acquisition of Piramal's Healthcare Solutions Business
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 May 2010
Boston Scientific Announces Schedule for EuroPCR 2010
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2010
Abbott Receives FDA Approval for First Fully Automated Blood Test for 'Kissing Bug' Disease
Diagnostics FDA
 HSMN NewsFeed - 17 May 2010
First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy
Regenerative Medicine Interventional Cardiology
 HSMN NewsFeed - 14 May 2010
Epizyme Appoints Mikel Moyer, Ph.D., Vice President of Molecular Discovery
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Abbott
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.